Neural thread protein gene expression and detection of alzheimer's disease |
| A need exists for a definitive diagnostic test which can be performed on individuals suspected of ... |
|
Method of detecting neurological disease or dysfunction |
| What is claimed is: 1. A method for detecting the presence of nPTP in a human subject, said method ... |
|
Metabolic pathway assay |
| This invention relates to an in vitro screening assay which identifies enzyme inhibitors. This ... |
|
MurC |
| What is claimed is: 1. An isolated polynucleotide segment comprising a first polynucleotide ... |
|
Murf gene and enzyme of Pseudomonas aeruginosa |
| Polynucleotides and polypeptides of Pseudomonas aeruginosa MurF, an enzyme involved in bacterial ... |
|
Isoform specific inhibition for treatment of pain and reduction of anesthetic threshold |
| It is an object of the invention to provide a method of affecting nociception. It is an object of ... |
|
Liposomal transfection method |
| The object of the present invention is thus a method for transfecting a cell with a nucleic acid ... |
|
Antihelminthic anthraquinones and method of use thereof |
| OF THE INVENTION All patents, patent applications, government publications, government regulations,... |
|
Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA |
| The invention is directed to a new method of inducing viral mutagenesis which is useful in cell ... |
|
2'-Fluoronucleosides |
| OF THE INVENTION The invention as disclosed herein is a compound, method and composition for the ... |
|
|
Composotions and methods for radiographic imaging
| Details |
Inventors: Torchilin, Vladimir P.; Trubetskoy, Vladimir S.; Wolf, Gerald L.; Gazelle, G. Scott;
Assignee: The General Hospital Corporation (Boston, MA)
Primary Examiner: Hollinden; Gary E.
Assistant Examiner:
Attorney, Agent or Firm: Fish & Richardson P.C.
A radiographic imaging agent including a plurality of block copolymers forming a micelle, the block copolymers including a hydrophilic polymer linked to a hydrophobic polymer, and the hydrophobic polymer including a backbone incorporating radiopaque molecules via covalent bonds. |
|
DETAILED DESCRIPTION The present invention is a micellar iodine-containing block copolymer (MICBC) useful as a radiographic imaging agent. These micelle-forming block copolymers include a hydrophilic polymer linked to a hydrophobic polymer that includes a backbone incorporating radiopaque molecules. The imaging agent incorporates high levels of radiopaque molecules, which are normally insoluble, into the backbone of the hydrophobic polymer. The hydrophilic polymer imparts solubility to the imaging agent, and also allows it to avoid quick uptake by the reticuloendothelial system (RES). The micellar imaging agent thus allows high quantities of radiopaque molecules, adequate to permit detection with current imaging techniques, to be administered to an individual. The micellar imaging agents are of sufficient size (approximately 100-150 nm) that they do not quickly diffuse into the interstitial space upon intravenous administration. Therefore, using MICBCs, radiographic imaging can be performed for longer periods of time than with low molecular weight contrast agents. MICBCs are especially useful for radiographic imaging of the blood pool; that is, the image of any vascularized region of the body can be enhanced by in vivo administration of MICBCs. Additionally, despite the high molecular weight of the MICBCs when administered as micelles, MICBCs are excreted via the kidney after the micelles break down. After MICBCs are administered intravenously, they are diluted in the bloodstream, and the micelles ultimately dissociate into individual block copolymer chains, or unimers. These unimers are of low molecular weight, and are therefore efficiently eliminated from the body. The rate at which MICBCs dissociate in vivo is a function of the molecular weights of the hydrophilic polymer and the backbone of the hydrophobic polymer, which together form the block copolymer. At the optimal molecular weights of each of these two polymer chains, the micellar structure exists for forty minutes to two hours once introduced into bodily fluids, during which time radiographic imaging can be performed
|
| Related patents |
|
|
Biocompatible microcapsules
This invention for the first time demonstrates the use of water soluble non-ionic polymers such as PEO to create resistance to cell adhesion on the surface of ...
|
|
|
Adeno-associated viral vector-based methods and compositions for introducing an expression cassette into a cell
What is claimed is: 1. A method for introducing a functional expression cassette into a cell, said method comprising: (a) providing a population of first and second ...
|
|
|
Phospholipid- or lipid-linked glycosaminoglycan and process for producing the same
What is claimed is: 1. A process for producing a phospholipid- or lipid-linked glycosaminoglycan represented by the following formula (VI), ##STR122## or a salt thereof, ...
|
|
|
Inhibition of excessive phospholipase A.sub.2 activity and/or production by non-antimicrobial tetracyclines
The present invention provides a method for treating mammals suffering from conditions associated with excess phospholipase A.sub.2 activity and/or production which ...
|
|
|
Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
OF THE INVENTION The invention describes methods and compositions for the treatment of rheumatoid arthritis and osteoarthritis and other conditions that manifest ...
|
|
|
A3AR agonists for the treatment of inflammatory arthritis
The invention is described in the following SUMMARY with reference to a therapeutic method for the treatment of inflammatory arthritis. It should be noted that in ...
|
|
|
Nucleic acids encoding high molecular weight major outer membrane protein of moraxella
The present invention is directed towards the provision of purified and isolated major outer membrane protein of Moraxella catarrhalis and other Moraxella strains, ...
|
|
|
Saponin adjuvant compositions
What is claimed is: 1. A Quillaja saponaria saponin composition for eliciting an immune response in an organism, comprising a combination of a substantially pure QS-7 ...
|
|
|
Quercetin derivatives and their medical usages
The invention claimed is: 1. A purified compound of formula I ##STR00002## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 are all or partly hydrogen atoms, or alkyl ...
|
|
|
Islet cells from human embryonic stem cells
This invention solves the problem of generating large populations of human islet cells by showing how to efficiently differentiate them from pluripotent stem cells. It ...
|
|
|